Skip to Main Content

Paper Details

Changes in Prostate-specific Antigen Screening after the 2018 United States Preventive Services Task Force Recommendations and Through the COVID-19 Pandemic.
Eur Urol Oncol
3
2024
COVID-19, PATIENT, PSA, Prostate-specific Antigen, men, prostate cancer, prostate-specific antigen
Author NameAffiliation
Xi ChenCenter for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School
Toni K ChoueiriLank Center for Genitourinary Oncology, Dana-Farber Cancer Institute, Brigham and Women's Hospital and Harvard Medical School
Stuart R LipsitzCenter for Surgery and Public Health, Brigham and Women's Hospital, Harvard Medical School
  • 1 - 3

Datasets

Release 1.2